4. Keratoplasty
Corneal transplantation / Corneal grafting
It is an operation in which the patient's diseased cornea
is excised and replaced by the healthy clear cornea.
HISTORY – First recorded therapeutic corneal xenograft
on a human was reported in 1838 by Richard Kissam
Father of Keratoplasty – V P Filatov
5.
6. OBJECTIVES :-
• To establish clear corneal visual axis
• To minimize refractive error
• To provide tectonic support
• To eliminate infection
7.
8.
9. Cornea as a transplant
✓ Absence of blood and lymphatic channel in the
graft and its bed
✓ Absence of MHC class II APCs in the graft
✓ Reduced expression of MHC coded alloantigen on
graft cells
✓ Immunosuppressive microenvironment of aqueous
humor.
10. Types :-
A. AUTOKERATOPLASTY -
1. ROTATIONAL KERATOPLASTY
2. CONTRALATERAL KERATOPLASTY
B. ALLO-KERATOPLASTY -
1. PENETRATING KERATOPLASTY
2. LAMELLAR KERATOPLASTY
3. SMALL PATCH GRAFT (for small
defects)
14. CONTRALATERAL KERATOPLASTY
• Cornea of one eye – opaque
• Other eye – blind due to some posterior segment
disease, but clear cornea
• Cornea of 2 eyes are exchanged with each other
15. PENETRATING KERATOPLASTY
• It is full thickness grafting
History :-
• First successful penetrating keratoplasty in humans was
done by Eduard Zirm (1905)
• Recipient – A 45 yr old farm laborer who had sustained
severe alkali burns while cleaning out chicken coop with
lime
• Donor – 11 yr old boy
• One cornea was used to provide two 5 mm donor grafts
18. OPTICAL
• Keratoplasty is performed to improve vision
• Important indications -
Corneal opacity
Bullous keratopathy
Corneal dystrophies, degenerations
Advanced keratoconus
Chemical injuries
21. TECTONIC
• To restore integrity of eyeball
• Indications-
Marked corneal thinning
(Stromal thinning, Descemetocele)
After corneal perforation
22. THERAPEUTIC
• To replace the infected corneal
tissue which is unresponsive to
conventional antimicrobial
therapy (Non healing corneal
ulcer)
-Selected cases of viral , bacterial,
fungal , protozoal keratitis
INFECTIOUS KERATITIS
23. COSMETIC
• To improve the appearance of the eye
• Cases of corneal opacities with posterior
segment disease where Visual improvement
is not possible.
• Opaque cornea with white or blue-grey hue
may be disturbing to the patient
24. LAMELLAR KERATOPLASTY
• Partial thickness grafting
• Selective removal of diseased tissue
and replacement with donor cornea.
• It is less invasive procedure
• But it requires finer surgical skill
and more refined instrumentation
25. ALTERNATIVE TO PKP – WHY ??
1. PKP induced astigmatism in range of 3 to 7
diopter.
2. Decline in endothelial cell count leading to graft
failure
3. Allograft rejection and endothelial
decompensation were the major concerns
26. HISTORY :-
The 1st successful lamellar keratoplasty was performed
by Arthur Von Hippel (1886).
He grafted rabbit cornea into the lamellar bed of a
young woman.
He is credited with the invention of mechanical trephine
for corneal procedures.
28. Superficial anterior lamellar keratoplasty
• Partial thickness excision of Corneal epithelium and
stroma
• Endothelium and part of deep stroma – left behind
• INDICATIONS:-
- Opacification of superficial 1/3rd of corneal stroma
- Marginal corneal thinning/infiltration as in reccurent
pterygium, marginal degeneration
- localized thinning or descemetocele formation
29.
30. DEEP ANTERIOR LAMELLAR KERATOPLASTY
• Opaque corneal tissue is removed almost to the level of Descemet
membrane.
• Decreased rejection risk (endothelium- major target of Rejection)
• INDICATIONS:-
- Disease involving anterior 95% of Corneal thickness (normal
endothelium, no breaks/scars in Descemet membrane)
- Chronic inflammatory disease- atopic keratoconjunctivitis which
carries increased risk of graft rejection.
31. POSTERIOR LAMELLAR KERATOPLASTY
• Performed when only endothelium is defective.
• It involves removal only of diseased endothelium along with
Descemet’s membrane, through a corneoscleral or corneal incision.
• Folded donor tissue is introduced through the same small (about 5
mm) incision.
• Maintains structural integrity. Decreases surgically induced
astigmatism.
33. • DMEK adds only a new Descemet's membrane and
endothelium.
• DSAEK also adds a new Descemet's membrane
and endothelium but with a layer of donor stroma.
Indications –
1. Fuchs endothelial dystrophy (most common)
2. Pseudophakic / Aphakic bullous keratopathy
3. Post PK endothelial graft rejection
4. Iridocorneal endothelial syndromes (ICE)
34.
35. Host factors affecting the prognosis
1. Severe stromal vascularization , extreme thinning at
the proposed graft – host junction
2. Abnormalities of the eyelids ( Blepharitis, Ectropion,
entropion, trichiasis)
3. Recurrent conjunctival inflammations, tear film
dysfunction
4. Anterior synechiae, Uncontrolled glaucoma
5. Anterior uveitis